Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment
NCT00480896
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
250
Enrollment
INDUSTRY
Sponsor class
Conditions
Dermatitis, Atopic
Interventions
DRUG:
tacrolimus ointment
DRUG:
Placebo ointment
Sponsor
Astellas Pharma Inc